HemOnc: CLL/SLL
Trial ID
05168930
Trial Sponsor
Dana Farber Cancer Institute
HemOnc: CLL/SLL (DFCI 21-279)
Description: A Phase 2 Trial of Zanubrutinib and Venetoclax in Previously Treated CLL/SLL Patients
HemOnc: CLL/SLL (DFCI 21-279)
Description: A Phase 2 Trial of Zanubrutinib and Venetoclax in Previously Treated CLL/SLL Patients